FDA rejects Allergan migraine drug on manufacturing issues
April 16, 2013 at 09:26 AM EDT
April 16 (Reuters) - U.S. health regulators rejected Allergan Inc's inhaled migraine drug, citing issues related to the company's canister filling unit.
